The above free vintage image of a laboratory is courtesy of iStock and Google Images.

Health Friday is a series devoted to information about Big Pharma, vaccines, general health, and associated topics.

There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are found here. NOTE: Yours Truly has checked today’s post for any AI-generated content. To the best of her knowledge and belief, there is none. If readers wish to post anything in the discussion thread for today that is AI-generated, they must cite their source. Thank you.

Today’s offering is Part Two (of two) regarding the HHS / NIH announcement regarding the establishment of the “Generation Gold Standard” for future development and testing of vaccines in the United States. “Generation Gold Standard” includes the development and testing of a “Universal Vaccine Platform”, which will incorporate elements from various viruses, including coronaviruses (such as the SARS-CoV-2 virus, aka the COVID-19 virus.) Part One can be found here: https://www.theqtree.com/2025/05/09/health-friday-5-9-2025-about-that-universal-vaccine-theres-more-than-meets-the-eye-part-one/. The HHS / NIH announcement is found here: https://www.hhs.gov/press-room/hhs-nih-announces-generation-gold-standard.html, 1 May 2025. Please refer to the screenshot below:

Yours Truly discussed several items in the above announcement in Part One, referred to above. Part Two is a further discussion of items related to the BPL-1357 intranasal “universal virus vaccine”, a “cornerstone” of the “Generation Gold Standard” program. The primary focus of Part Two will be on the “adjuvant” for BPL-1357, a compound called ALFQ. However, before the presentation, there is this short paper, from January 2025: https://doi.org/10.1093/ofid/ofae631.188, “593. Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine”, Jeffery Taubenberger, Matthew J. Memoli, et al., 29 January 2025. A screenshot of the Background section of the Abstract of this paper is below:

Note the description of BPL-1357: It is to cover several types of Avian Influenza viruses. Nothing about covering coronaviruses. Why was there a ‘challenge” with Influenza A type viruses, and nothing about “challenges” with Influenza virus types B or C (https://www.cdc.gov/flu/about/viruses-types.html.) How can BPL-1357 be considered a “Universal Vaccine” if it is only covers Avian Influenza viruses? How does this paper “stack up” vis-a-vis the HHS / NIH “Generation Gold Standard” announcement?

Then, there is the mysterious BPL-24910 (aka BPL-2491) vaccine, which is referred to in the HHS / NIH announcement, but of which there is no record at clinicaltrials.gov/, nor is much information available on the internet. Yours Truly was able to find a few items. The first one is here: https://www.ntd.com/health-officials-announce-new-effort-to-develop-universal-vaccines-targeting-multiple-virus-strains_1064264.html, by Zachary Stieber, 1 May 2025. Please see the screenshot from this article, below:

The NIAID awarded funds to a company called Lovelace Biomedical Research Institute for testing the toxicity of BPL-24910: https://www.usaspending.gov/award/CONT_AWD_75N93022F00001_7529_75N93021D00031_7529. Below are screenshots from this link:

Lovelace Biomedical Research Institute was founded in 1947 in Albuquerque, New Mexico. The institute joined Touro University in 2022. (https://www.lovelacebiomedical.org/, and Wikipedia.)

Now, on to the AFLQ “adjuvant” in BPL-1357:

ALFQ is a combination of two separate items: ALF plus QS21. ALF stands for monophosphoryl lipid A (aka 3D-PHAD.) It is also called “Army Liposome Formulation.” Please see the screenshot below, from https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monophosphoryl-lipid-a:

What is an endotoxin? Please see: https://www.britannica.com/science/endotoxin. A screenshot from the Britannica entry is below:

It is unclear which version of ALF is actually used in BPL-1357: the “LPS” version, or the “MPLA” version.

Then, there is 3D-PHAD. Please see below, from https://www.sigmaaldritch.com/:

And, more on ALF (aka Army Liposome Formulation) is here: https://pmc.ncbi.nlm.nih.gov/articles/PMC7412170/, “Army Liposome Formulation (ALF) Family of Vaccine Adjuvants”, Carl R Alving, et al, 7 August 2020. Please see the screenshot from this paper, below:

Note the reference to HIV-1. More on this later in today’s post.

ALFQ contains a TLR4 agonist. What is TLR4? Also known as CD284, it is a “key activator of the innate immune response”, per https://en.wikipedia.org/wiki/Toll-like_receptor_4. An agonist is an agent that interacts with a particular cellular receptor, and produces an observable positive response.

The other component of ALFQ is QS21. What is QS21? It is a vaccine adjuvant derived from the soapbark tree (Quillaja saponaria.) QS21 is used in the Novavax COVID-19 “vaccine” as an adjuvant, as part of the company’s “Matrix-M” ingredient.

QS21 has been studied for some time. Here is an article, from the John Innes Centre, that describes the history of QS21: https://www.jic.ac.uk/advances/the-quest-for-qs-21/, Winter 2020-2021. Please see a screenshot from this article, below:

Yours Truly now presents some “interesting information.” One is not making any judgements or opinions; the reader may make their own. This has to do with the HIV-1 reference above in the post. The first item is this: https://doi.org/10.1016/S0264-410X(00)00415-1, “QS21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans”, Thomas G. Evans, et al., 28 February 2001. A screenshot of the Abstract of this paper is below:

The second item is here: https://worldcouncilforhealth.substack.com/cp/162703289, “BOMBSHELL: HIV Contamination Found In Moderna’s Covid Shot”, 2 May 2025. There are actually two bombshells here: two separate molecules related to HIV-1 were found in the Moderna modRNA COVID-19 “vaccine” — gp145 and gp120. Please see the screenshots from the World Council for Health article, below:

The graphic created by Dr. McKernan, from the above article, showing where the gp145 HIV-1 molecule is in the Moderna modRNA COVID-19 “vaccine” sequence:

Regarding the gp120 HIV-1 molecule in the Moderna mRNA-1273 modRNA COVID-19 “vaccine”, it was the famous (or, infamous) “Pradhan, et al., paper” from January 2020 which showed that there were gp120 HIV-1 molecules in the SARS-CoV-2 (COVID-19) virus itself. The “Pradhan, et al., paper” was Withdrawn shortly after its publication, and is now difficult to find. Yours Truly was able to locate the paper here: https://academia.edu/79020098/Uncanny_similarity_of_unique_inserts_in_the_2019_nCoV_spike-protein_to_HIV_1_gp_120_and_Gag?f_ri-170, “Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag”, Prashant Pradhan, et al., 31 January 2020. A screenshot from the paper is below:

Recall that in January 2020, there were no COVID-19 “vaccines” in use anywhere. Note also that the gp120 HIV-1 molecule is present in the COVID-19 virus itself spike protein. Did the Pfizer-BioNTech developers of BNT162b2 remove any or all of the four HIV-1 related inserts in the COVID-19 spike protein (found by Pradhan, et al.) in the process of working on their “vaccine”? Why did Moderna leave the gp120 HIV-1 molecule (and also, it turns out, the gp145 HIV-1 molecule) in that company’s modRNA COVID-19 “vaccine”, mRNA-1273?

And, there is the involvement of the United States Army in HIV research (this is in addition to the Army’s developing the “adjuvant”, ALFQ): https://hivresearch.org/hiv-research/alf-adjuvants. This is the Military HIV Research Program.

Yours Truly will reiterate that one is not making judgements or opinions here; readers will make their own. However, the following needs to be said: the gp120 molecule in HIV-1 attacks the body’s CD4 cells. Please see this paper, from 2010: https://pubmed.ncbi.nlm.nih.gov/20088758/, “The GP120 molecule of HIV-1 and its interaction with T cells”, V Yoon, et al., 2010. A screenshot of the Abstract of this paper is below:

Also: the SARS-CoV-2 virus itself attacks the body’s CD4 cells: https://doi.org/10.7554/eLife.84790, “SARS-CoV-2 uses CD4 to infect T helper lymphocytes”, Natalia S Brunetti, et al., 31 July 2023. A screenshot of the Abstract of this paper is below:

And, there is this paper: https://doi.org/10.3389/fimmu.2020.596631, “Sharing CD4+ T cell Loss: When COVID-19 and HIV Collide on Immune System”, Jean-Pierre Routy, et al., 14 December 2020. Note that this paper was published just a few days after the initial EUAs were granted by the FDA for BNT162b2 and for mRNA-1273 in the United States (11 December 2020); therefore, the research into writing the Routy, et al., paper must have been accomplished at least a few months prior to December 2020. A screenshot of the opening statement of the paper is below:

Yours Truly will ask a question that perhaps is “inconvenient”, but needs to be asked: Is any potential connection between the presence of the gp120 HIV-1 molecule in the SARS-CoV-2 virus itself, AND its potential presence in the Pfizer-BioNTech modRNA COVID-19 “vaccines”, AND its potential presence in the Novavax COVID-19 “vaccine” (which uses the original SARS-CoV-2 virus itself spike protein as a foundation), AND the confirmed presence of BOTH the gp120 HIV-1 molecule and the gp145 HIV-1 molecule in the Moderna modRNA COVID-19 “vaccines” — with the multiple serious Adverse Events reports of autoimmune / immune-mediated, and related conditions, that are in the Appendix 1: List of Adverse Events of Special Interest section of this report: ttps://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf?

Another “inconvenient” question posed by Yours Truly: What, if anything, did Dr. Anthony Fauci, Dr. Francis Collins, Dr. Deborah Birx, Dr. Robert Redfield, and Dr. Janet Woodcock know about the presence of the gp120 HIV-1 molecule in the SARS-CoV-2 virus itself spike protein, AND in the Moderna modRNA COVID-19 “vaccine” mRNA-1273?

What will be done to make absolutely sure that there is NO molecule whatsoever related to HIV-1 present in the “Universal Vaccine” candidates BPL-1357 and BPL-24910, or in any other “Universal Vaccine” candidates? What will be done to hold accountable the people who allowed the gp120 HIV-1 molecule to be present in the original SARS-CoV-2 virus itself? What will be done to investigate the potential presence of the gp120 HIV-1 molecule in the Pfizer-BioNTech modRNA COVID-19 “vaccines”? What will be done to hold accountable the people who allowed HIV-1 molecules gp120 AND gp145 to be present in the Moderna modRNA COVID-19 “vaccines”?

THERE. MUST. BE. JUSTICE.

Peace, Good Energy, Respect: PAVACA